Andrew Schubkegel, MD
Otolaryngology · Clarendon Hills, ILNPI 1275521320
Payments from drug & device makers
Across 75 payments — averaging $60.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$373
- Medtronic$270
- Alk-abello, Inc$239
- Stryker$196
- Mylan Specialty L.p.$116
- plus $416 from 11 others
What the payments were for
- Consulting fees$2,67059%
- Travel & lodging$1754%
- Food & beverage$1,66137%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 12 | $2,897 |
| Regeneron Healthcare Solutions, Inc. | 11 | $373 |
| Medtronic | 8 | $270 |
| Alk-abello, Inc | 9 | $239 |
| Stryker | 7 | $196 |
| Mylan Specialty L.p. | 6 | $116 |
| Acclarent, Inc | 6 | $113 |
| GSK | 3 | $72 |
| Hikma Pharmaceuticals USA | 3 | $54 |
| Sanofi | 2 | $36 |
| Intersect ENT, Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Smith+Nephew | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Cochlear Americas | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $14 |
| Cook Medical LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$2,675
How this compares
$4,507 in reported general payments places this provider in the 80th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 49 | $2,530 |
| Azelastine Hcl | 39 | $1,211 |
| Cefdinir | 38 | $815 |
| Fluticasone Propionate | 46 | $802 |
| Pantoprazole Sodium | 27 | $581 |
| Ipratropium Bromide | 11 | $430 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $357 |
| Montelukast Sodium | 33 | $218 |
| Dexamethasone | 30 | $111 |
| Prednisone | 41 | $81 |
| Amoxicillin | 12 | $59 |
| Azithromycin | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Clarendon Hills
- Bruce TanChicago$940K
- Jayant PintoChicago$747K
- David ConleyChicago$630K
- Robert KernChicago$610K
- Mihir BhayaniChicago$298K
- Charles WeingartenGlenview$268K
- Samer Al-KhudariChicago$251K
- Robert NaclerioBurr Ridge$229K
- T K VenkatesanChicago$223K
- Bobby TajudeenChicago$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.